Soltis Investment Advisors LLC Abb Vie Inc. Transaction History

Soltis Investment Advisors LLC

$1.01 Billion
Q3 2024

A detailed history of Soltis Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 47,458 shares of ABBV stock, worth $8.33 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

47,458

Previous 48,223 1.59%

Holding current value

$8.33 Million

Previous $8.27 Million 13.31%

% of portfolio

0.93%

Previous 0.88%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$163.84 - $199.33 $125,337 - $152,487	-765 Reduced 1.59%	47,458 $9.37 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $4.43 Million - $5.18 Million	28,649 Added 146.36%	48,223 $8.27 Million
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $159 - $182	1 Added 0.01%	19,574 $3.56 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $104,163 - $117,312	-757 Reduced 3.72%	19,573 $3.03 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $72,138 - $83,511	540 Added 2.73%	20,330 $3.03 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $30,874 - $38,421	233 Added 1.19%	19,790 $2.67 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $199,995 - $230,324	1,383 Added 7.61%	19,557 $3.12 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $52,834 - $63,362	382 Added 2.15%	18,174 $2.94 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $22,949 - $26,322	171 Added 0.97%	17,792 $2.39 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $125,096 - $159,038	909 Added 5.44%	17,621 $2.7 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $23,888 - $29,638	181 Added 1.09%	16,712 $2.71 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $859 - $1,087	-8 Reduced 0.05%	16,531 $2.24 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $17,236 - $19,566	162 Added 0.99%	16,539 $1.78 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $631 - $703	-6 Reduced 0.04%	16,377 $1.85 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $5,115 - $5,631	50 Added 0.31%	16,383 $1.77 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $9,819 - $13,257	-122 Reduced 0.74%	16,333 $1.75 Million
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $1.22 Million - $1.44 Million	14,232 Added 640.22%	16,455 $1.44 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $163,101 - $218,254	2,223 New	2,223 $218,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.

Account

Soltis Investment Advisors LLC Abb Vie Inc. Transaction History